Physician-authored. Peer-reviewed sources. No sponsored content. Just research you can trust.
Deep-dive into the science behind peptides and protocols.
Specialized pro-resolving mediators (SPMs) β resolvins, protectins, and maresins derived from EPA and DHA β actively terminate inflammation through specific receptor pathways rather than passively suppressing it. This reframes how we understand omega-3 biology.
The ERRΞ±/Ξ²/Ξ³ nuclear receptor family controls the transcriptional programs that make muscle fatigue-resistant. Targeting these orphan receptors is the molecular foundation of 'exercise in a pill' pharmacology.
Adenosine is the molecular currency of sleep pressure. Its accumulation during wakefulness inhibits wake-promoting neurons via A1 and A2A receptors β a system caffeine hijacks and modern life disrupts.
BDNF is the master regulator of synaptic plasticity, governing memory formation and neuronal survival. Specific peptides can upregulate BDNF expression and reverse stress-induced cognitive decline.
Magnesium is not just a generic mineral β it is the voltage-dependent plug inside every NMDA receptor. When intracellular MgΒ²βΊ falls, the gate fails, glutamate becomes excitotoxic, and synaptic plasticity collapses.
Magnesium isn't just a generic mineral β it's the voltage-dependent gatekeeper of NMDA receptors. Intracellular MgΒ²βΊ depletion drives excitotoxicity, impaired LTP, and accelerated cognitive decline.
Specialized pro-resolving mediators (SPMs) are bioactive lipid metabolites of EPA and DHA that actively orchestrate inflammation resolution. They don't suppress inflammation β they end it.
Oral NMN, oral NR, and direct NAD+ infusion produce strikingly different tissue distributions. Understanding the Slc12a8 transporter and first-pass metabolism explains why route of administration β not just dose β determines which organs actually see an NAD+ rise.
The route of administration β oral NMN, oral NR, or parenteral NAD+ β dramatically changes which tissues actually receive NAD+ precursor uplift. Pharmacokinetics, not dose, often determines clinical outcome.
AMPK is the master energy-sensing kinase that switches cells from anabolic storage to catabolic fat oxidation. Research links its activation to improved insulin sensitivity, autophagy, and healthspan.